Advertisement

Advertisement

AMPH Stock Latest News

Amphastar downgraded to Hold from Buy at Jefferies

The FlyAmphastar downgraded to Hold from Buy at Jefferies

Amphastar price target lowered to $23 from $30 at Barclays

PremiumThe Fly

Amphastar price target lowered to $23 from $30 at Barclays

26d ago

Amphastar Expands Share Repurchase Authorization to Manage Equity

PremiumCompany Announcements

Amphastar Expands Share Repurchase Authorization to Manage Equity

2M ago

Amphastar Updates Executive Employment Agreements to Strengthen Leadership

PremiumCompany Announcements

Amphastar Updates Executive Employment Agreements to Strengthen Leadership

2M ago

Amphastar Pharmaceuticals Balances Growth Plans With Margin Risks

PremiumCompany Announcements

Amphastar Pharmaceuticals Balances Growth Plans With Margin Risks

2M ago

Amphastar price target lowered to $30 from $34 at Wells Fargo

PremiumThe FlyAmphastar price target lowered to $30 from $34 at Wells Fargo

2M ago

Amphastar reports Q4 EPS 73c, consensus 92c

The Fly

Amphastar reports Q4 EPS 73c, consensus 92c

2M ago

Amphastar gets FDA approval for Ipratropium Bromide HFA Inhalation Aerosol ANDA

The Fly

Amphastar gets FDA approval for Ipratropium Bromide HFA Inhalation Aerosol ANDA

2M ago

AMPH Upcoming Earnings Report: What to Expect?

PremiumPre-Earnings

AMPH Upcoming Earnings Report: What to Expect?

2M ago

Amphastar Licenses ACTH Analog AMP-110 for North America

PremiumCompany Announcements

Amphastar Licenses ACTH Analog AMP-110 for North America

4M ago

Amphastar price target lowered to $30 from $31 at BofA

PremiumThe Fly

Amphastar price target lowered to $30 from $31 at BofA

4M ago

Amphastar Pharmaceuticals Receives Buy Rating Following FDA Approval of AMP-015

PremiumRatings

Amphastar Pharmaceuticals Receives Buy Rating Following FDA Approval of AMP-015

5M ago

Amphastar announces FDA approval for teriparatide injection

PremiumThe FlyAmphastar announces FDA approval for teriparatide injection

5M ago

Amphastar initiated with an Equal Weight at Barclays

The Fly

Amphastar initiated with an Equal Weight at Barclays

5M ago

Amphastar Pharmaceuticals’ Resilient Q3 2025 Earnings Call

Company Announcements

Amphastar Pharmaceuticals’ Resilient Q3 2025 Earnings Call

6M ago

Amphastar Pharmaceuticals: Strong Q3 Performance and Promising Pipeline Justify Buy Rating

PremiumRatings

Amphastar Pharmaceuticals: Strong Q3 Performance and Promising Pipeline Justify Buy Rating

6M ago

Amphastar Pharmaceuticals Reports Q3 2025 Earnings

PremiumCompany Announcements

Amphastar Pharmaceuticals Reports Q3 2025 Earnings

6M ago

Amphastar reports Q3 adjusted EPS 93c, consensus 83c

PremiumThe Fly

Amphastar reports Q3 adjusted EPS 93c, consensus 83c

6M ago

AMPH Upcoming Earnings Report: What to Expect?

PremiumPre-Earnings

AMPH Upcoming Earnings Report: What to Expect?

6M ago

Amphastar Expands BAQSIMI® Distribution in Asia

PremiumCompany AnnouncementsAmphastar Expands BAQSIMI® Distribution in Asia

6M ago

Amphastar Pharmaceuticals: Strategic Shift and Growth Catalysts Justify Buy Rating with $36 Target

Ratings

Amphastar Pharmaceuticals: Strategic Shift and Growth Catalysts Justify Buy Rating with $36 Target

6M ago

Amphastar price target lowered to $31 from $32 at BofA

The Fly

Amphastar price target lowered to $31 from $32 at BofA

7M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >